Julie E. Hammack - Concepedia

Author

Julie E. Hammack

Also Known As

J E Hammack, J Hammack, J. E. Hammack, J. Hammack, J. Hammack MD, J.E. Hammack, JULIE E. HAMMACK, Julie E Hammack, Julie E. Hammack, Julie Elaine Hammack

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona WinnMed Mayo Clinic in Florida Hematology Oncology Associates

About

Julie E. Hammack is an author at Mayo Clinic specializing in medicine, neurology, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1K
2	Health Sciences	7	7	556
3	Social Sciences	1	1	30
4	Anesthesia	1	1	226
5	Emergency Medicine	1	1	21

Julie E. Hammack

Publications

Citations

H-Index

Page 1

	Year	Citations
Neurological Complications Associated With Anti–Programmed Death 1 (PD-1) Antibodies Justin Kao, Bing Liao, Svetomir N. Markovic, JAMA Neurology	2017	304
Phase II Trial of Procarbazine, Lomustine, and Vincristine as Initial Therapy for Patients With Low-Grade Oligodendroglioma or Oligoastrocytoma: Efficacy and Associations With Chromosomal Abnormalities Jan C. Buckner, Dean H. Gesme, Judith R. OʼFallon, Journal of Clinical Oncology	2003	245
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy Julie E. Hammack, John C. Michalak, Charles L. Loprinzi, Pain Crossover TrialPain MedicineNeuropathic PainPharmacotherapyCddp-induced Peripheral Neuropathy	2002	226
Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study Nadia N. Laack, Paul D. Brown, Robert J. Ivnik, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyNeuropsychologyRadiation TherapyGliomaMedicine	2005	160
Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute Derek R. Johnson, Paul D. Brown, Evanthia Galanis, Journal of Neuro-Oncology Neuro-oncologyNational Cancer InstituteSurgical OncologyMedicineCancer Management	2012	132
Paraneoplastic Cerebellar Degeneration: A Clinical Comparison of Patients With and Without Purkinje Cell Cytoplasmic Antibodies Julie E. Hammack, David W. Kimmel, Brian Patrick O’Neill, Mayo Clinic Proceedings PathologyClinical ComparisonNeurologyNeuropathologyMedicine	1990	119
Regular use of a verbal pain scale improves the understanding of oncology inpatient pain intensity. Eva Y. M. Au, Charles L. Loprinzi, M Dhodapkar, Journal of Clinical Oncology	1994	87
Conditional probability of long‐term survival in glioblastoma Derek R. Johnson, Jim Daniel, Jan C. Buckner, Cancer	2012	84
Choroid Plexus Papillomas: A Single Institutional Experience Sunil Krishnan, Paul D. Brown, Bernd W. Scheithauer, Journal of Neuro-Oncology Single Institutional ExperienceOculoplasticsHistopathologySurgeryChoroid Plexus	2004	78
Status epilepticus: Clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients Amanuel Amare, Guta Zenebe, Julie E. Hammack, Epilepsia	2008	69

Page 1